Neurologist and clinical neuroscientist Philipp Mergenthaler is researching the relationship between two basic cytological processes: glucose metabolism and programmed cell death, otherwise known as apoptosis. In his project at Charité – Universitätsmedizin, Mergenthaler observes how these two processes interact in mitochondrial diseases, i.e. disorders that are triggered when mitochondria are damaged. His research will also consider bioenergetic defects and dysfunctional mitochondria as mechanisms of neurodegenerative diseases such as Alzheimer’s and Parkinson’s disease. Mergenthaler works at the Department of Neurology with Experimental Neurology at Charité – Universitätsmedizin and at the Center for Stroke Research Berlin (CSB). He is an alumnus of the BIH Charité Clinician Scientist Program.
For Research. For Berlin.